From cytology to HPV based screening - Part B: Other countries: operational experiences from transforming screening programs: lessons learned
Monday, December 3, 2018
Main Scientific Session
•
MSS 04b
•
5:30 PM
>
6:15 PM
•
From cytology to HPV based screening - Part B: Other countries: operational experiences from transforming screening programs: lessons learned
•
Auditorium I
Available technology for cervical cancer prevention has changed dramatically since recognition that infection with oncogenic HPVs is the necessary cause of cervical cancer in mid 1980ies. Before the so-called “HPV-era” cytology was used for screening, follow-up of inconclusive screening outcomes and treated women. Liquid based cytology and automated reading improved the performance of cytology tests, however the most influential initiative was the evidence that periodic testing of symptom free population will result in detection and treatment of cervical precancers. Mass screening, as a public health policy, has proved to be a powerful tool to diagnose and treat cervical precancers. Consequently, dramatic reductions in cervical cancer incidence and mortality have been observed. Currently, commercialized HPV-tests have been used, alone or with cytology, in screening, follow-up of inconclusive screening outcomes and treated women. HPV-testing of self-sampled vaginal specimens allows the inclusion of sub-optimally screened women in screening programs, reducing therefore clinical appointments. Furthermore, it is unclear what the role of existing commercial HPV-tests is in screening of HPV-vaccinated women. Tailoring together a screening program to deliver the best possible prevention against cervical cancer is a challenge for public health policy providers. In this session, affluent, medium and low-income countries, which have adopted HPV-methodology for primary screening, present their experience.
5:30 PM
•
MSS 04b-01
•
Turkey
>
M.
Murat
GULTEKIN
5:39 PM
•
MSS 04b-02
•
USA
>
W.
Walter
KINNEY
5:48 PM
•
MSS 04b-03
•
Australia
>
J.
Julia
BROTHERTON
5:57 PM
•
MSS 04b-04
•
China
>
F-H.
Fang-Hui
ZHAO
6:06 PM
•
MSS 04b-05
•
Discussion
|